PATTERNOX
Innovative imaging to detect skin and lesion deformities for cosmetics and skin cancer
Company Overview
Snapshot
Founded in September 2019 by Ofir Aharon, PATTERNOX operates with 1–10 employees. The company has raised $500,000 across one funding round. In February 2025, PATTERNOX secured Pre-Seed funding, underscoring investor confidence in its early-stage development.
Business overview
PATTERNOX LTD develops an innovative imaging method called Lateral Movements of Backscattered-light (LMB) to detect tissue distortions. This technology identifies early indicators of skin deformities, such as those that could progress into skin cancer or cosmetic concerns, by analyzing sub-surface distortions rather than relying on color changes. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices, Diagnostics Devices, Digital Healthcare, and Digital Medical Diagnostics, serving healthcare providers with its non-invasive diagnostic solutions.
Strategic signal
In February 2025, PATTERNOX received Pre-Seed funding, a significant validation for its innovative imaging technology. This investment signals strong early-stage investor confidence in the company's potential to revolutionize skin cancer diagnosis and cosmetic assessment by providing early detection capabilities, which could significantly impact patient outcomes and the dermatology market.
Log in to access full profile ›Company Intelligence Q&A
- What is PATTERNOX's core technology?
- PATTERNOX has developed an innovative imaging method called Lateral Movements of Backscattered-light (LMB). This technology extracts tissue distortions below the skin surface, enabling early detection of skin and lesion deformities for cosmetic and skin cancer applications.
- When was PATTERNOX founded?
- PATTERNOX was founded in September 2019 by Ofir Aharon.
- What recognition did PATTERNOX receive in February 2025?
- In February 2025, PATTERNOX was awarded the First Prize by Migdal and Shark Tank for its innovative lesion distortions scanner device.
- What is the primary application of PATTERNOX's technology?
- PATTERNOX's technology is primarily used for the early detection of skin cancer and cosmetic concerns by identifying tissue distortions before they manifest as visible color changes.
- What is the name of PATTERNOX's primary product?
- PATTERNOX's primary product is called PatScope, a device designed for the early examination of skin cancer.